retatrutide phase 2 trial new england journal of medicine Cristobal Morales on X: "Triple Hormone Receptor Agonist #Retatrutide for Obesity A @NEJM @LillyTrials At 48 weeks, the least-squares mean percentage change in the groups was −8.7% in Retatrutide (GLP-3) Results: What Trials

Carney JA

Injectable GLP-1s and Breast Milk Many injectable GLP-1 medications are large peptide molecules, which naturally limits how much can pass into breast milk

Also, the active ingredients in weight loss injections have been used to treat diabetes for years before being adapted for weight loss treatment

One exchange initially treated Canadian artwork as suspicious because it differed from the familiar U.S

Providers should also monitor renal function and gastrointestinal side effects during follow-up

Preliminary studies show promising reductions in body weight, apneahypopnea index (AHI), and systemic inflammation, although long-term trials remain warranted